Variant report

Variant	esv3355758
Chromosome Location	chr1:10925990-10928738
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:24)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:24 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr1:10574408..10575004-chr1:10926842..10927727,2	K562	blood:
2	chr1:10489961..10490892-chr1:10926816..10927795,3	K562	blood:
3	chr1:10554756..10555464-chr1:10926875..10927459,2	K562	blood:
4	chr1:10834395..10836864-chr1:10924588..10926735,2	MCF-7	breast:
5	chr1:10568670..10571119-chr1:10926842..10928478,2	K562	blood:
6	chr1:10562142..10564951-chr1:10926770..10929049,2	K562	blood:
7	chr1:10895615..10898736-chr1:10923813..10928307,5	K562	blood:
8	chr1:10919663..10923359-chr1:10925488..10928766,3	MCF-7	breast:
9	chr1:10911727..10913949-chr1:10927458..10930368,2	K562	blood:
10	chr1:10892514..10895346-chr1:10924391..10927017,2	K562	blood:
11	chr1:10927411..10929903-chr1:10960980..10963469,2	MCF-7	breast:
12	chr1:10923092..10926846-chr1:10929418..10932147,4	K562	blood:
13	chr1:10926964..10929247-chr1:10959901..10962873,4	MCF-7	breast:
14	chr1:10590066..10590945-chr1:10927189..10927789,2	K562	blood:
15	chr1:10751694..10755124-chr1:10925813..10928871,3	MCF-7	breast:
16	chr1:10927850..10929832-chr1:10934675..10937595,2	K562	blood:
17	chr1:10923927..10926846-chr1:10929418..10932147,3	K562	blood:
18	chr1:10567095..10568153-chr1:10926865..10927880,8	K562	blood:
19	chr1:10914701..10916708-chr1:10923191..10926876,3	MCF-7	breast:
20	chr1:10926420..10929831-chr1:10932404..10934606,3	K562	blood:
21	chr1:10752227..10753991-chr1:10926922..10928500,5	MCF-7	breast:
22	chr1:10925966..10930455-chr1:10932404..10937595,5	K562	blood:
23	chr1:10576160..10578872-chr1:10926632..10929593,2	MCF-7	breast:
24	chr1:10754807..10756455-chr1:10925799..10928452,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000175279	chromatin interactions
ENSG00000271989	chromatin interactions
ENSG00000251503	chromatin interactions
ENSG00000130940	chromatin interactions

Extended variants
information (count: 84 )
Associated
traits (count: 110 )

Variant overlapped rSNPs/rCNVs (count:84 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs560587941	chr1:10926056-10926057	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Bivalent/Poised TSS Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs527782656	chr1:10926098-10926099	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Bivalent/Poised TSS Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs548571716	chr1:10926126-10926127	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Bivalent/Poised TSS Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs2790694	chr1:10926127-10926128	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Bivalent/Poised TSS Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs371991010	chr1:10926234-10926235	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs560726489	chr1:10926360-10926361	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs531523057	chr1:10926389-10926390	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs549630429	chr1:10926390-10926391	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs570916888	chr1:10926399-10926400	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs202186587	chr1:10926490-10926491	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs538580073	chr1:10926512-10926513	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs1281002	chr1:10926560-10926561	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs527299547	chr1:10926593-10926594	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs552118915	chr1:10926597-10926598	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs369394796	chr1:10926622-10926623	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs535951699	chr1:10926647-10926648	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs556026777	chr1:10926763-10926764	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs574260585	chr1:10926802-10926803	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs190803569	chr1:10926827-10926828	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs556855291	chr1:10926832-10926833	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs577962404	chr1:10926892-10926893	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
22	rs112672852	chr1:10926906-10926907	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
23	rs34896200	chr1:10926916-10926917	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs36047809	chr1:10926966-10926967	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs542684256	chr1:10926968-10926969	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs565387120	chr1:10926975-10926976	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs531360236	chr1:10927019-10927020	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs549665251	chr1:10927026-10927027	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
29	rs567904938	chr1:10927079-10927080	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
30	rs575688258	chr1:10927095-10927096	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
31	rs35236487	chr1:10927117-10927118	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs565519663	chr1:10927153-10927154	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
33	rs6657949	chr1:10927202-10927203	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
34	rs536371908	chr1:10927248-10927249	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
35	rs548276349	chr1:10927400-10927401	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
36	rs567869452	chr1:10927436-10927437	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
37	rs538395703	chr1:10927494-10927495	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
38	rs371000167	chr1:10927495-10927496	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
39	rs556793661	chr1:10927542-10927543	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
40	rs12022541	chr1:10927552-10927553	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
41	rs141294447	chr1:10927559-10927560	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
42	rs57672845	chr1:10927590-10927591	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
43	rs538940888	chr1:10927608-10927609	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
44	rs113425255	chr1:10927614-10927615	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
45	rs572315732	chr1:10927627-10927628	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
46	rs35934669	chr1:10927680-10927681	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
47	rs553791443	chr1:10927729-10927730	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
48	rs565930537	chr1:10927741-10927742	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
49	rs542721517	chr1:10927772-10927773	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
50	rs183002154	chr1:10927819-10927820	Bivalent Enhancer Enhancers Bivalent/Poised TSS Genic enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:110)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Follicular lymphoma	18703704	CNVD
Lung cancer	22429812	CNVD
Epilepsy	22118685	CNVD
Schizophrenia	22118685	CNVD
Ovarian cancer	21720365	CNVD
Developmental delay	19490664	CNVD
Ewing''s sarcoma	21437220	CNVD
Prader-willi syndrome	18797701	CNVD
periventricular nodular heterotopia	20648244	CNVD
1p36 deletion syndrome	22283845	CNVD
Cervical cancer	21062161	CNVD
Cancer	21183584	CNVD
Follicular lymphoma	20505157	CNVD
Neuroblastoma	18923524	CNVD
Retinoblastoma	22278416	CNVD
Mental retardation	20152051	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Astrocytoma	17934521	CNVD
Glioblastoma	20031968	CNVD
Acute myeloid leukemia	18000384	CNVD
Glioblastoma multiforme	16951158	CNVD
Neuroblastoma	18574593	CNVD
Glioblastoma multiforme	17369134	CNVD
Autism	18414403	CNVD
Breast cancer	17001317	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Myoepithelioma	18604193	CNVD
Wilms tumour	19047088	CNVD
Breast cancer	16608533	CNVD
T-cell lymphomas	19863542	CNVD
Hepatocellular carcinoma	16750200	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Breast cancer	17133270	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Metanephric adenoma	20802469	CNVD
Soft tissue tumor	16732325	CNVD
Papillary thyroid carcinoma	21436994	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Colorectal cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Coronary Disease	20032323	CNVD
Prostate cancer	21965145	CNVD
Stargardt''s disease	17277736	CNVD
Neuroblastoma	17897457	CNVD
Uveal melanoma	21693616	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Neuroblastoma	21484798	CNVD
Non-syndromic sensorineural hearing loss	22290220	CNVD
Liposarcoma	21253554	CNVD
Breast cancer	21264507	CNVD
Acute myeloid leukemia	16864856	CNVD
Astrocytoma	17387387	CNVD
Cancer	21499728	CNVD
Glioblastoma multiforme	17387387	CNVD
Oligodendroglial tumors	17285580	CNVD
Neuroblastoma	17535989	CNVD
Pheochromocytoma	17535989	CNVD
Prostate cancer	16705090	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Neuroblastoma	17533364	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Chronic myeloid leukemia	21384125	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Neuroblastoma	18923191	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Non-small cell lung cancer	21385341	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Chordoma	21602918	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Multiple myeloma	16461302	CNVD
Glioblastoma multiforme	21138945	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Ovarian neoplasms	16753589	CNVD
Neuroblastoma	19287153	CNVD
Hepatocellular carcinoma	18929564	CNVD
Melanoma	17363583	CNVD
renal disease	17924346	CNVD
Uveal melanoma	20484589	CNVD
Multiple myeloma	16616336	CNVD
Glioblastoma multiforme	22286061	CNVD
Myelofibrosis	22110671	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	20808228	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD

Chromatin state (count:403 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:10918600-10926600	Weak transcription	Esophagus	oesophagus
2	chr1:10920000-10926800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
3	chr1:10920200-10926800	Bivalent Enhancer	Fetal Muscle Leg	muscle
4	chr1:10921200-10926600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
5	chr1:10921600-10926000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
6	chr1:10921600-10926800	Weak transcription	Gastric	stomach
7	chr1:10922000-10926200	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
8	chr1:10922800-10926800	Weak transcription	Right Atrium	heart
9	chr1:10923000-10926800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
10	chr1:10923600-10926600	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
11	chr1:10923800-10926000	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
12	chr1:10924400-10926800	Weak transcription	Psoas Muscle	Psoas
13	chr1:10924600-10926000	Weak transcription	Fetal Heart	heart
14	chr1:10924800-10926600	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
15	chr1:10924800-10926800	Weak transcription	Liver	Liver
16	chr1:10925200-10926600	Weak transcription	Pancreas	Pancrea
17	chr1:10925400-10926000	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
18	chr1:10925600-10926600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
19	chr1:10925800-10926000	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
20	chr1:10925800-10926000	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
21	chr1:10925800-10926000	Bivalent Enhancer	Fetal Lung	lung
22	chr1:10925800-10926000	Enhancers	Right Ventricle	heart
23	chr1:10925800-10926200	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
24	chr1:10925800-10926400	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
25	chr1:10925800-10926400	Bivalent Enhancer	Brain Germinal Matrix	brain
26	chr1:10925800-10926600	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
27	chr1:10925800-10926600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
28	chr1:10925800-10926600	Bivalent Enhancer	Fetal Stomach	stomach
29	chr1:10925800-10928000	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
30	chr1:10926000-10926200	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
31	chr1:10926000-10926200	Bivalent Enhancer	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
32	chr1:10926000-10926200	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
33	chr1:10926000-10926200	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
34	chr1:10926000-10926200	Enhancers	Brain Angular Gyrus	brain
35	chr1:10926000-10926200	Bivalent/Poised TSS	Fetal Kidney	kidney
36	chr1:10926000-10926400	Weak transcription	Right Ventricle	heart
37	chr1:10926000-10926600	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
38	chr1:10926000-10926600	Enhancers	Breast Myoepithelial Primary Cells	Breast
39	chr1:10926000-10926600	Enhancers	Primary hematopoietic stem cells	blood
40	chr1:10926000-10926600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
41	chr1:10926000-10926800	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
42	chr1:10926000-10926800	Enhancers	Skeletal Muscle Female	skeletal muscle
43	chr1:10926000-10927800	Active TSS	H9 Cell Line	embryonic stem cell
44	chr1:10926000-10927800	Bivalent Enhancer	Primary B cells from peripheral blood	blood
45	chr1:10926000-10927800	Enhancers	Fetal Heart	heart
46	chr1:10926000-10928600	Bivalent Enhancer	Fetal Brain Male	brain
47	chr1:10926200-10926600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
48	chr1:10926200-10927600	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
49	chr1:10926200-10927600	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
50	chr1:10926200-10927800	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links